Some Heart Risks Stay Elevated in RA Patients Despite Biologic Tx
Hopes that biologic drugs for rheumatoid arthritis (RA) would cancel the extra cardiovascular risks normally seen with the disease dimmed a little in the face of findings from a population-based study from Scandinavia. Over the first 5 years after beginning biologic agents such as tumor necrosis factor (TNF) and interleukin (IL) inhibitors, RA patients in …
Some Heart Risks Stay Elevated in RA Patients Despite Biologic Tx Read More »